Correlation Between Merit Medical and Cytek Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merit Medical and Cytek Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merit Medical and Cytek Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merit Medical Systems and Cytek Biosciences, you can compare the effects of market volatilities on Merit Medical and Cytek Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merit Medical with a short position of Cytek Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merit Medical and Cytek Biosciences.

Diversification Opportunities for Merit Medical and Cytek Biosciences

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Merit and Cytek is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Merit Medical Systems and Cytek Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytek Biosciences and Merit Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merit Medical Systems are associated (or correlated) with Cytek Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytek Biosciences has no effect on the direction of Merit Medical i.e., Merit Medical and Cytek Biosciences go up and down completely randomly.

Pair Corralation between Merit Medical and Cytek Biosciences

Given the investment horizon of 90 days Merit Medical Systems is expected to generate 0.39 times more return on investment than Cytek Biosciences. However, Merit Medical Systems is 2.56 times less risky than Cytek Biosciences. It trades about 0.05 of its potential returns per unit of risk. Cytek Biosciences is currently generating about -0.01 per unit of risk. If you would invest  7,371  in Merit Medical Systems on September 1, 2024 and sell it today you would earn a total of  3,019  from holding Merit Medical Systems or generate 40.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Merit Medical Systems  vs.  Cytek Biosciences

 Performance 
       Timeline  
Merit Medical Systems 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Merit Medical Systems are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Merit Medical may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Cytek Biosciences 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cytek Biosciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile forward-looking signals, Cytek Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Merit Medical and Cytek Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merit Medical and Cytek Biosciences

The main advantage of trading using opposite Merit Medical and Cytek Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merit Medical position performs unexpectedly, Cytek Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytek Biosciences will offset losses from the drop in Cytek Biosciences' long position.
The idea behind Merit Medical Systems and Cytek Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites